Exane Derivatives’s Innovator US Equity Buffer ETF December BDEC Stock Holding History
Bought
Maintained
Sold
Other funds holding BDEC
W
BA
PCM
OMC
BCM
Exane Derivatives's BDEC Position: Q2 2022 in Review
Exane Derivatives held its Innovator US Equity Buffer ETF December (BDEC) position steady in Q2 2022 at 1,962 shares worth $59.7K. The position accounts for 0.03% of the portfolio, ranked #304.
Exane Derivatives first reported a position in BDEC in Q4 2020 and has held it in 7 quarters since. The position peaked at $139K in Q3 2021. 43 funds tracked by Wall St. Rank hold BDEC as of Q2 2022.
- Exane Derivatives held 1,962 shares of Innovator US Equity Buffer ETF December worth $59.7K as of Q2 2022.
- Exane Derivatives left its Innovator US Equity Buffer ETF December share count unchanged in Q2 2022.
- Innovator US Equity Buffer ETF December made up 0.03% of Exane Derivatives's portfolio in Q2 2022, its #304 holding.
- Exane Derivatives first reported a position in Innovator US Equity Buffer ETF December in Q4 2020 and has held it in 7 quarters since.
- Exane Derivatives's Innovator US Equity Buffer ETF December position peaked at $139K in Q3 2021.
- 43 funds tracked by Wall St. Rank held Innovator US Equity Buffer ETF December as of Q2 2022.
Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.